ge-20210923

0000040545-21-000058.txt : 20210923 0000040545-21-000058.hdr.sgml : 20210923 20210923081712 ACCESSION NUMBER: 0000040545-21-000058 CONFORMED SUBMISSION TYPE: 8-K PUBLIC DOCUMENT COUNT: 14 CONFORMED PERIOD OF REPORT: 20210923 ITEM INFORMATION: Other Events ITEM INFORMATION: Financial Statements and Exhibits FILED AS OF DATE: 20210923 DATE AS OF CHANGE: 20210923 FILER: COMPANY DATA: COMPANY CONFORMED NAME: GENERAL ELECTRIC CO CENTRAL INDEX KEY: 0000040545 STANDARD INDUSTRIAL CLASSIFICATION: ELECTRONIC & OTHER ELECTRICAL EQUIPMENT (NO COMPUTER EQUIP) [3600] IRS NUMBER: 140689340 STATE OF INCORPORATION: NY FISCAL YEAR END: 1231 FILING VALUES: FORM TYPE: 8-K SEC ACT: 1934 Act SEC FILE NUMBER: 001-00035 FILM NUMBER: 211271096 BUSINESS ADDRESS: STREET 1: 5 NECCO STREET CITY: BOSTON STATE: MA ZIP: 02210 BUSINESS PHONE: 617-443-3000 MAIL ADDRESS: STREET 1: 5 NECCO STREET CITY: BOSTON STATE: MA ZIP: 02210 8-K 1 ge-20210923.htm 8-K ge-20210923

UNITED STATES

SECURITIES AND EXCHANGE COMMISSION

Washington, D.C. 20549

FORM 8-K

CURRENT REPORT

Pursuant to Section 13 or 15(d) of The Securities Exchange Act of 1934

Date of Report (Date of earliest event reported) September 23, 2021

General Electric Company

(Exact name of registrant as specified in its charter)

New York

001-00035

14-0689340

(State or other jurisdiction
of incorporation)

(Commission
File Number)

(IRS Employer
Identification No.)

5 Necco Street

Boston,

02210

(Address of principal executive offices)

(Zip Code)

(Registrant’s telephone number, including area code) (617) 443-3000

_______________________________________________

(Former name or former address, if changed since last report.)

Check the appropriate box below if the Form 8-K filing is intended to simultaneously satisfy the filing obligation of the registrant under any of the following provisions (see General Instructions A.2. below):


☐			Written communications pursuant to Rule 425 under the Securities Act (17 CFR 230.425)
☐			Soliciting material pursuant to Rule 14a-12 under the Exchange Act (17 CFR 240.14a-12)
☐			Pre-commencement communications pursuant to Rule 14d-2(b) under the Exchange Act (17 CFR 240.14d-2(b))
☐			Pre-commencement communications pursuant to Rule 13e-4(c) under the Exchange Act (17 CFR 240.13e-4(c))

Securities registered pursuant to Section 12(b) of the Act:


Title of each class	Trading Symbol(s)	Name of each exchange on which registered
Common stock, par value $0.01 per share	GE	New York Stock Exchange
0.375% Notes due 2022	GE 22A	New York Stock Exchange
1.250% Notes due 2023	GE 23E	New York Stock Exchange
0.875% Notes due 2025	GE 25	New York Stock Exchange
1.875% Notes due 2027	GE 27E	New York Stock Exchange
1.500% Notes due 2029	GE 29	New York Stock Exchange
7 1/2% Guaranteed Subordinated Notes due 2035	GE /35	New York Stock Exchange
2.125% Notes due 2037	GE 37	New York Stock Exchange


			Indicate by check mark whether the registrant is an emerging growth company as defined in Rule 405 of the Securities Act of 1933 (§230.405 of this chapter) or Rule 12b-2 of the Securities Exchange Act of 1934 (§ 240.12b-2 of this chapter).
			Emerging growth company			☐
			If an emerging growth company, indicate by check mark if the registrant has elected not to use the extended transition period for complying with any new or revised financial accounting standards pursuant to Section 13(a) of the Exchange Act.			☐

Item 8.01 Other Events.

On September 23, 2021, General Electric Company issued a press release announcing the entry into an agreement to acquire BK Medical, a leader in advanced surgical visualization, from Altaris Capital Partners for a cash purchase price of $1.45 billion. The parties expect the transaction to close in 2022, subject to review by the relevant regulatory authorities.

Item 9.01 Financial Statements and Exhibits.

(d) Exhibits

Exhibit 99.1 is being furnished as part of this report.


Exhibit No.						Description

99.1						Press release, dated September 23, 2021 issued by General Electric Company
104						The cover page from this Current Report on Form 8-K, formatted in Inline XBRL

This document contains “forward-looking statements”—that is, statements related to future, not past, events. These forward-looking statements often address our expected future business and financial performance and financial condition, and often contain words such as "expect," "anticipate," "intend," "plan," "believe," "seek," "see," "will," "would," "estimate," "forecast," "target," "preliminary," or "range." Forward-looking statements by their nature address matters that are, to different degrees, uncertain, and are subject to risks, uncertainties and assumptions. Should one or more of these risks or uncertainties materialize, or should underlying assumptions prove incorrect, actual results may vary materially from those indicated or anticipated by such forward-looking statements. The inclusion of such statements should not be regarded as a representation that such plans, estimates or expectations will be achieved. Important factors that could cause actual results to differ materially from such plans, estimates or expectations include, among others, (1) that one or more closing conditions to the transaction, including certain regulatory approvals, may not be satisfied or waived, on a timely basis or otherwise, including that a governmental entity may prohibit, delay or refuse to grant approval for the consummation of the proposed transaction, may require conditions, limitations or restrictions in connection with such approvals; (2) the risk that the proposed transaction may not be completed in the expected time frame, or at all; (3) uncertainty of the expected financial performance of GE Healthcare or BK Medical following completion of the proposed transaction, or failure to realize the anticipated benefits of the proposed transaction; and (4) other risk factors as detailed from time to time in GE’s reports filed with the SEC, including GE’s annual report on Forms 10-K, periodic quarterly reports on Form 10-Q, periodic current reports on Form 8-K and other documents filed with the SEC. The foregoing list of important factors is not exclusive.

(2)

SIGNATURES

Pursuant to the requirements of the Securities Exchange Act of 1934, the registrant has duly caused this report to be signed on its behalf by the undersigned hereunto duly authorized.


						General Electric Company
						(Registrant)

Date: September 23, 2021						/s/ Michael J. Holston
						Michael J. Holston Senior Vice President, General Counsel and Secretary

(3)

EX-99.1 2 bkmedicalpr.htm EX-99.1 Document

Exhibit 99.1

GE Healthcare to Acquire BK Medical, Expanding Ultrasound Portfolio into Surgical Visualization

•Complementary acquisition supports GE Healthcare’s $3 billion Ultrasound business’ expansion from diagnostics into surgical and therapeutic interventions

•Creates compelling customer offering and accelerates GE Healthcare’s growth in precision health

•Adds capability in fast-growing advanced surgical visualization segment; attractive-margin business serving accretive, high-growth segments

BOSTON – September 23, 2021 – GE (NYSE:GE) has entered into an agreement to acquire BK Medical, a leader in advanced surgical visualization, from Altaris Capital Partners for a cash purchase price of $1.45 billion.

BK Medical is an innovator in global intraoperative imaging and surgical navigation, used to guide clinicians during minimally invasive and robotic surgeries and to visualize deep tissue during procedures in neuro and abdominal surgery, and in ultrasound urology. BK Medical is headquartered in Boston and Copenhagen with more than 650 employees and is delivering double-digit revenue growth.

GE Healthcare President and CEO Kieran Murphy said, “Ultrasound today forms an integral part of many care pathways, and BK Medical is a strategic and highly complementary addition to our growing and profitable Ultrasound business. This transaction helps GE Healthcare continue to expand beyond diagnostics into surgical and therapeutic interventions, simplifying decision-making for clinicians and equipping them with greater insights to deliver faster, more personalized care for their patients—representing another step toward delivering precision health.”

BK Medical President and CEO Brooks West said, “We are immensely proud of the organization and of the life-changing technology that we have built at BK Medical, and look forward to our future as part of the GE Healthcare family. Combining our expertise in intraoperative imaging and surgical navigation with GE Healthcare’s many strengths and global presence will accelerate our mission to change the standard of care in surgical interventions. Our mission to help surgeons make critical decisions using active imaging aligns well with GE Healthcare’s mission to help physicians make more informed decisions and improve patient outcomes, and we are eager to begin this new chapter.”

GE Healthcare Ultrasound President and CEO Roland Rott said, “Adding the fast-growing and relatively new field of real-time surgical visualization to GE’s pre- and post-operative Ultrasound capabilities will create an end-to-end offering through the full continuum of care—from diagnosis through therapy and beyond. GE Healthcare and BK Medical share a passion for clinical innovation, and I’m excited to welcome BK Medical to our team.”

This transaction is expected to create value by further strengthening BK Medical, including through significant synergies with the benefit of GE’s technology and commercial scale. This transaction enables BK Medical’s Active Imaging platform to reach new customers and new markets around the world, and the combination of GE Healthcare’s diagnostic imaging technology with BK’s ability to enable decision-making and surgical visualization in intervention will allow better decision-making throughout the care continuum. GE Healthcare expects BK Medical to deliver rapid revenue growth as well as margin expansion and free cash flow growth. GE Healthcare also expects high-single-digit return on invested capital by year five.

The parties expect the transaction to close in 2022, subject to review by the relevant regulatory authorities.

Evercore acted as exclusive financial advisor to GE on the transaction. Gibson, Dunn and Crutcher acted as legal advisor to GE. J.P. Morgan Securities LLC served as lead financial advisor, Morgan Stanley & Co. LLC served as financial advisor, and Latham Watkins LLP and Schiff Hardin LLP acted as legal advisor to BK Medical.

Forward-looking statements

About GE

GE (NYSE:GE) rises to the challenge of building a world that works. For more than 125 years, GE has invented the future of industry, and today the company’s dedicated team, leading technology, and global reach and capabilities help the world work more efficiently, reliably, and safely. GE’s people are diverse and dedicated, operating with the highest level of integrity and focus to fulfill GE’s mission and deliver for its customers. www.ge.com

About GE Healthcare:

GE Healthcare is the $17 billion* healthcare business of GE (NYSE: GE). As a leading global medical technology, pharmaceutical diagnostics and digital solutions innovator, GE Healthcare enables clinicians to make faster, more informed decisions through intelligent devices, data analytics, applications and services, supported by its Edison intelligence platform. With over 100 years of healthcare industry experience and around 47,000 employees globally, the company operates at the center of an ecosystem working toward precision health, digitizing healthcare, helping drive productivity and improve outcomes for patients, providers, health systems and researchers around the world.

Follow us on Facebook, LinkedIn, Twitter, and Insights for the latest news, or visit our website www.gehealthcare.com for more information.

*Excluding BioPharma.

About BK Medical

BK Medical is a global intraoperative imaging and surgical navigation company with headquarters in Boston and Copenhagen and more than 650 employees worldwide. Through the advanced ultrasound technology and sophisticated software algorithms of its active imaging platform, BK Medical enables surgeons to make real-time, data-based decisions during surgical procedures, resulting in better clinical outcomes and reduced costs for patients, physicians, and the healthcare system. With 40 years of expertise in advanced ultrasound technology, the company has a global installed base of more than 14,000 ultrasound platforms. BK Medical technology is highly proprietary and protected with more than 136 patent families. For more information, please visit www.bkmedical.com.

About Altaris

Altaris is an investment firm focused exclusively on the healthcare industry. Altaris seeks to invest in companies that deliver value to the healthcare system and improve patient outcomes by providing innovative products and services. Since inception in 2003, Altaris has invested in more than 40 companies across its five main investment funds. Altaris has $5.9 billion of equity capital under active management and is headquartered in New York, NY. For more information, please visit www.altariscap.com.

GE Healthcare Media Contacts

Jennifer Fox

+1 414 530 3027

Jennifer.R.Fox@ge.com

Hannah Huntly

GE Healthcare

Hannah.huntly@ge.com

+44 7887 824201

BK Medical Media Contact

Jehana Ray

857.995.7449

jray@bkmedical.com

GE Investor Contact

Steve Winoker

617.443.3400

swinoker@ge.com

GE Media Contact

Mary Kate Mullaney

202.304.6514

marykate.nevin@ge.com

EX-101.SCH 3 ge-20210923.xsd XBRL TAXONOMY EXTENSION SCHEMA DOCUMENT 0001001 - Document - Cover Page link:presentationLink link:calculationLink link:definitionLink EX-101.DEF 4 ge-20210923_def.xml XBRL TAXONOMY EXTENSION DEFINITION LINKBASE DOCUMENT EX-101.LAB 5 ge-20210923_lab.xml XBRL TAXONOMY EXTENSION LABEL LINKBASE DOCUMENT 1.875% Notes Due 2027 [Member] 1.875% Notes Due 2027 [Member] 1.875% Notes Due 2027 [Member] Entity Address, State or Province Entity Address, State or Province Entity Tax Identification Number Entity Tax Identification Number Title of 12(b) Security Title of 12(b) Security Entity File Number Entity File Number 2.125% Notes Due 2037 [Member] 2.125% Notes Due 2037 [Member] 2.125% Notes Due 2037 [Member] Written Communications Written Communications 0.875% Notes Due 2025 [Member] 0.875% Notes Due 2025 [Member] 0.875% Notes Due 2025 [Member] Entity Emerging Growth Company Entity Emerging Growth Company Soliciting Material Soliciting Material 7.5% Guaranteed Subordinated Notes Due 2035 [Member] 7.5% Guaranteed Subordinated Notes Due 2035 [Member] 7.5% Guaranteed Subordinated Notes Due 2035 [Member] City Area Code City Area Code Entity Incorporation, State or Country Code Entity Incorporation, State or Country Code Entity Address, Address Line One Entity Address, Address Line One Entity Information [Line Items] Entity Information [Line Items] Local Phone Number Local Phone Number Cover [Abstract] Cover [Abstract] Pre-commencement Tender Offer Pre-commencement Tender Offer Amendment Flag Amendment Flag 0.375% Notes Due 2022 [Member] 0.375% Notes Due 2022 [Member] 0.375% Notes Due 2022 [Member] Common Stock [Member] Common Stock [Member] Pre-commencement Issuer Tender Offer Pre-commencement Issuer Tender Offer Trading Symbol Trading Symbol Document Period End Date Document Period End Date Class of Stock [Domain] Class of Stock [Domain] 1.500% Notes Due 2029 [Member] 1.500% Notes Due 2029 [Member] 1.500% Notes Due 2029 [Member] Document Type Document Type Class of Stock [Axis] Class of Stock [Axis] Entity Registrant Name Entity Registrant Name 1.250% Notes Due 2023 [Member] 1.250% Notes Due 2023 [Member] 1.250% Notes Due 2023 [Member] Entity Address, City or Town Entity Address, City or Town Entity Address, Postal Zip Code Entity Address, Postal Zip Code Entities [Table] Entities [Table] Entity Central Index Key Entity Central Index Key Security Exchange Name Security Exchange Name EX-101.PRE 6 ge-20210923_pre.xml XBRL TAXONOMY EXTENSION PRESENTATION LINKBASE DOCUMENT XML 7 ge-20210923_htm.xml IDEA: XBRL DOCUMENT 0000040545 2021-09-23 2021-09-23 0000040545 us-gaap:CommonStockMember 2021-09-23 2021-09-23 0000040545 ge:A0.375NotesDue2022Member 2021-09-23 2021-09-23 0000040545 ge:A1.250NotesDue2023Member 2021-09-23 2021-09-23 0000040545 ge:A0.875NotesDue2025Member 2021-09-23 2021-09-23 0000040545 ge:A1.875NotesDue2027Member 2021-09-23 2021-09-23 0000040545 ge:A1.500NotesDue2029Member 2021-09-23 2021-09-23 0000040545 ge:A7.5GuaranteedSubordinatedNotesDue2035Member 2021-09-23 2021-09-23 0000040545 ge:A2.125NotesDue2037Member 2021-09-23 2021-09-23 0000040545 false 8-K 2021-09-23 General Electric Co NY 001-00035 14-0689340 5 Necco Street Boston, MA 02210 617 443-3000 false false false false Common stock, par value $0.01 per share GE NYSE 0.375% Notes due 2022 GE 22A NYSE 1.250% Notes due 2023 GE 23E NYSE 0.875% Notes due 2025 GE 25 NYSE 1.875% Notes due 2027 GE 27E NYSE 1.500% Notes due 2029 GE 29 NYSE 7 1/2% Guaranteed Subordinated Notes due 2035 GE /35 NYSE 2.125% Notes due 2037 GE 37 NYSE false XML 8 R1.htm IDEA: XBRL DOCUMENT

Cover Page	Sep. 23, 2021
Entity Information [Line Items]
Document Type	8-K
Document Period End Date	Sep. 23, 2021
Entity Registrant Name	General Electric Co
Entity Central Index Key	0000040545
Amendment Flag	false
Entity Incorporation, State or Country Code	NY
Entity File Number	001-00035
Entity Tax Identification Number	14-0689340
Entity Address, Address Line One	5 Necco Street
Entity Address, City or Town	Boston,
Entity Address, State or Province	MA
Entity Address, Postal Zip Code	02210
City Area Code	617
Local Phone Number	443-3000
Written Communications	false
Soliciting Material	false
Pre-commencement Tender Offer	false
Pre-commencement Issuer Tender Offer	false
Entity Emerging Growth Company	false
Common Stock [Member]
Entity Information [Line Items]
Title of 12(b) Security	Common stock, par value $0.01 per share
Trading Symbol	GE
Security Exchange Name	NYSE
0.375% Notes Due 2022 [Member]
Entity Information [Line Items]
Title of 12(b) Security	0.375% Notes due 2022
Trading Symbol	GE 22A
Security Exchange Name	NYSE
1.250% Notes Due 2023 [Member]
Entity Information [Line Items]
Title of 12(b) Security	1.250% Notes due 2023
Trading Symbol	GE 23E
Security Exchange Name	NYSE
0.875% Notes Due 2025 [Member]
Entity Information [Line Items]
Title of 12(b) Security	0.875% Notes due 2025
Trading Symbol	GE 25
Security Exchange Name	NYSE
1.875% Notes Due 2027 [Member]
Entity Information [Line Items]
Title of 12(b) Security	1.875% Notes due 2027
Trading Symbol	GE 27E
Security Exchange Name	NYSE
1.500% Notes Due 2029 [Member]
Entity Information [Line Items]
Title of 12(b) Security	1.500% Notes due 2029
Trading Symbol	GE 29
Security Exchange Name	NYSE
7.5% Guaranteed Subordinated Notes Due 2035 [Member]
Entity Information [Line Items]
Title of 12(b) Security	7 1/2% Guaranteed Subordinated Notes due 2035
Trading Symbol	GE /35
Security Exchange Name	NYSE
2.125% Notes Due 2037 [Member]
Entity Information [Line Items]
Title of 12(b) Security	2.125% Notes due 2037
Trading Symbol	GE 37
Security Exchange Name	NYSE

EXCEL 9 Financial_Report.xlsx IDEA: XBRL DOCUMENT begin 644 Financial_Report.xlsx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end XML 10 Show.js IDEA: XBRL DOCUMENT // Edgar(tm) Renderer was created by staff of the U.S. Securities and Exchange Commission. Data and content created by government employees within the scope of their employment are not subject to domestic copyright protection. 17 U.S.C. 105. var Show={};Show.LastAR=null,Show.showAR=function(a,r,w){if(Show.LastAR)Show.hideAR();var e=a;while(e&&e.nodeName!='TABLE')e=e.nextSibling;if(!e||e.nodeName!='TABLE'){var ref=((window)?w.document:document).getElementById(r);if(ref){e=ref.cloneNode(!0); e.removeAttribute('id');a.parentNode.appendChild(e)}} if(e)e.style.display='block';Show.LastAR=e};Show.hideAR=function(){Show.LastAR.style.display='none'};Show.toggleNext=function(a){var e=a;while(e.nodeName!='DIV')e=e.nextSibling;if(!e.style){}else if(!e.style.display){}else{var d,p_;if(e.style.display=='none'){d='block';p='-'}else{d='none';p='+'} e.style.display=d;if(a.textContent){a.textContent=p+a.textContent.substring(1)}else{a.innerText=p+a.innerText.substring(1)}}} XML 11 report.css IDEA: XBRL DOCUMENT /* Updated 2009-11-04 */ /* v2.2.0.24 */ /* DefRef Styles */ ..report table.authRefData{ background-color: #def; border: 2px solid #2F4497; font-size: 1em; position: absolute; } ..report table.authRefData a { display: block; font-weight: bold; } ..report table.authRefData p { margin-top: 0px; } ..report table.authRefData .hide { background-color: #2F4497; padding: 1px 3px 0px 0px; text-align: right; } ..report table.authRefData .hide a:hover { background-color: #2F4497; } ..report table.authRefData .body { height: 150px; overflow: auto; width: 400px; } ..report table.authRefData table{ font-size: 1em; } /* Report Styles */ ..pl a, .pl a:visited { color: black; text-decoration: none; } /* table */ ..report { background-color: white; border: 2px solid #acf; clear: both; color: black; font: normal 8pt Helvetica, Arial, san-serif; margin-bottom: 2em; } ..report hr { border: 1px solid #acf; } /* Top labels */ ..report th { background-color: #acf; color: black; font-weight: bold; text-align: center; } ..report th.void { background-color: transparent; color: #000000; font: bold 10pt Helvetica, Arial, san-serif; text-align: left; } ..report .pl { text-align: left; vertical-align: top; white-space: normal; width: 200px; white-space: normal; /* word-wrap: break-word; */ } ..report td.pl a.a { cursor: pointer; display: block; width: 200px; overflow: hidden; } ..report td.pl div.a { width: 200px; } ..report td.pl a:hover { background-color: #ffc; } /* Header rows... */ ..report tr.rh { background-color: #acf; color: black; font-weight: bold; } /* Calendars... */ ..report .rc { background-color: #f0f0f0; } /* Even rows... */ ..report .re, .report .reu { background-color: #def; } ..report .reu td { border-bottom: 1px solid black; } /* Odd rows... */ ..report .ro, .report .rou { background-color: white; } ..report .rou td { border-bottom: 1px solid black; } ..report .rou table td, .report .reu table td { border-bottom: 0px solid black; } /* styles for footnote marker */ ..report .fn { white-space: nowrap; } /* styles for numeric types */ ..report .num, .report .nump { text-align: right; white-space: nowrap; } ..report .nump { padding-left: 2em; } ..report .nump { padding: 0px 0.4em 0px 2em; } /* styles for text types */ ..report .text { text-align: left; white-space: normal; } ..report .text .big { margin-bottom: 1em; width: 17em; } ..report .text .more { display: none; } ..report .text .note { font-style: italic; font-weight: bold; } ..report .text .small { width: 10em; } ..report sup { font-style: italic; } ..report .outerFootnotes { font-size: 1em; } XML 12 FilingSummary.xml IDEA: XBRL DOCUMENT 3.21.2 html 9 96 1 false 8 0 false 0 false false R1.htm 0001001 - Document - Cover Page Sheet http://www.ge.com/role/CoverPage Cover Page Cover 1 false false All Reports Book All Reports ge-20210923.htm bkmedicalpr.htm ge-20210923.xsd ge-20210923_def.xml ge-20210923_lab.xml ge-20210923_pre.xml http://fasb.org/us-gaap/2021-01-31 http://xbrl.sec.gov/dei/2021 true false JSON 14 MetaLinks.json IDEA: XBRL DOCUMENT { "instance": { "ge-20210923.htm": { "axisCustom": 0, "axisStandard": 1, "contextCount": 9, "dts": { "definitionLink": { "local": [ "ge-20210923_def.xml" ] }, "inline": { "local": [ "ge-20210923.htm" ] }, "labelLink": { "local": [ "ge-20210923_lab.xml" ] }, "presentationLink": { "local": [ "ge-20210923_pre.xml" ] }, "schema": { "local": [ "ge-20210923.xsd" ], "remote": [ "https://xbrl.fasb.org/us-gaap/2021/elts/us-gaap-2021-01-31.xsd", "http://www.xbrl.org/2003/xbrl-instance-2003-12-31.xsd", "http://www.xbrl.org/2003/xbrl-linkbase-2003-12-31.xsd", "http://www.xbrl.org/2003/xl-2003-12-31.xsd", "http://www.xbrl.org/2003/xlink-2003-12-31.xsd", "https://www.xbrl.org/dtr/type/2020-01-21/types.xsd", "https://www.xbrl.org/2020/extensible-enumerations-2.0.xsd", "http://www.xbrl.org/2005/xbrldt-2005.xsd", "http://www.xbrl.org/2006/ref-2006-02-27.xsd", "https://xbrl.fasb.org/us-gaap/2021/elts/us-types-2021-01-31.xsd", "https://xbrl.fasb.org/srt/2021/elts/srt-types-2021-01-31.xsd", "https://xbrl.fasb.org/srt/2021/elts/srt-2021-01-31.xsd", "https://xbrl.sec.gov/country/2021/country-2021.xsd", "https://xbrl.fasb.org/srt/2021/elts/srt-roles-2021-01-31.xsd", "https://xbrl.fasb.org/us-gaap/2021/elts/us-roles-2021-01-31.xsd", "https://xbrl.sec.gov/dei/2021/dei-2021.xsd", "http://www.xbrl.org/lrr/role/negated-2009-12-16.xsd", "http://www.xbrl.org/lrr/role/net-2009-12-16.xsd" ] } }, "elementCount": 35, "entityCount": 1, "hidden": { "http://xbrl.sec.gov/dei/2021": 2, "total": 2 }, "keyCustom": 0, "keyStandard": 96, "memberCustom": 7, "memberStandard": 1, "nsprefix": "ge", "nsuri": "http://www.ge.com/20210923", "report": { "R1": { "firstAnchor": { "ancestors": [ "span", "div", "body", "html" ], "baseRef": "ge-20210923.htm", "contextRef": "i327e85bc0c1f45829eb4382a51c25ae1_D20210923-20210923", "decimals": null, "first": true, "lang": "en-US", "name": "dei:DocumentType", "reportCount": 1, "unique": true, "unitRef": null, "xsiNil": "false" }, "groupType": "document", "isDefault": "true", "longName": "0001001 - Document - Cover Page", "role": "http://www.ge.com/role/CoverPage", "shortName": "Cover Page", "subGroupType": "", "uniqueAnchor": { "ancestors": [ "span", "div", "body", "html" ], "baseRef": "ge-20210923.htm", "contextRef": "i327e85bc0c1f45829eb4382a51c25ae1_D20210923-20210923", "decimals": null, "first": true, "lang": "en-US", "name": "dei:DocumentType", "reportCount": 1, "unique": true, "unitRef": null, "xsiNil": "false" } } }, "segmentCount": 8, "tag": { "dei_AmendmentFlag": { "auth_ref": [], "lang": { "en-us": { "role": { "documentation": "Boolean flag that is true when the XBRL content amends previously-filed or accepted submission.", "label": "Amendment Flag", "terseLabel": "Amendment Flag" } } }, "localname": "AmendmentFlag", "nsuri": "http://xbrl.sec.gov/dei/2021", "presentation": [ "http://www.ge.com/role/CoverPage" ], "xbrltype": "booleanItemType" }, "dei_CityAreaCode": { "auth_ref": [], "lang": { "en-us": { "role": { "documentation": "Area code of city", "label": "City Area Code", "terseLabel": "City Area Code" } } }, "localname": "CityAreaCode", "nsuri": "http://xbrl.sec.gov/dei/2021", "presentation": [ "http://www.ge.com/role/CoverPage" ], "xbrltype": "normalizedStringItemType" }, "dei_CoverAbstract": { "auth_ref": [], "lang": { "en-us": { "role": { "documentation": "Cover page.", "label": "Cover [Abstract]", "terseLabel": "Cover [Abstract]" } } }, "localname": "CoverAbstract", "nsuri": "http://xbrl.sec.gov/dei/2021", "xbrltype": "stringItemType" }, "dei_DocumentPeriodEndDate": { "auth_ref": [], "lang": { "en-us": { "role": { "documentation": "For the EDGAR submission types of Form 8-K: the date of the report, the date of the earliest event reported; for the EDGAR submission types of Form N-1A: the filing date; for all other submission types: the end of the reporting or transition period. The format of the date is YYYY-MM-DD.", "label": "Document Period End Date", "terseLabel": "Document Period End Date" } } }, "localname": "DocumentPeriodEndDate", "nsuri": "http://xbrl.sec.gov/dei/2021", "presentation": [ "http://www.ge.com/role/CoverPage" ], "xbrltype": "dateItemType" }, "dei_DocumentType": { "auth_ref": [], "lang": { "en-us": { "role": { "documentation": "The type of document being provided (such as 10-K, 10-Q, 485BPOS, etc). The document type is limited to the same value as the supporting SEC submission type, or the word 'Other'.", "label": "Document Type", "terseLabel": "Document Type" } } }, "localname": "DocumentType", "nsuri": "http://xbrl.sec.gov/dei/2021", "presentation": [ "http://www.ge.com/role/CoverPage" ], "xbrltype": "submissionTypeItemType" }, "dei_EntitiesTable": { "auth_ref": [], "lang": { "en-us": { "role": { "documentation": "Container to assemble all relevant information about each entity associated with the document instance", "label": "Entities [Table]", "terseLabel": "Entities [Table]" } } }, "localname": "EntitiesTable", "nsuri": "http://xbrl.sec.gov/dei/2021", "presentation": [ "http://www.ge.com/role/CoverPage" ], "xbrltype": "stringItemType" }, "dei_EntityAddressAddressLine1": { "auth_ref": [], "lang": { "en-us": { "role": { "documentation": "Address Line 1 such as Attn, Building Name, Street Name", "label": "Entity Address, Address Line One", "terseLabel": "Entity Address, Address Line One" } } }, "localname": "EntityAddressAddressLine1", "nsuri": "http://xbrl.sec.gov/dei/2021", "presentation": [ "http://www.ge.com/role/CoverPage" ], "xbrltype": "normalizedStringItemType" }, "dei_EntityAddressCityOrTown": { "auth_ref": [], "lang": { "en-us": { "role": { "documentation": "Name of the City or Town", "label": "Entity Address, City or Town", "terseLabel": "Entity Address, City or Town" } } }, "localname": "EntityAddressCityOrTown", "nsuri": "http://xbrl.sec.gov/dei/2021", "presentation": [ "http://www.ge.com/role/CoverPage" ], "xbrltype": "normalizedStringItemType" }, "dei_EntityAddressPostalZipCode": { "auth_ref": [], "lang": { "en-us": { "role": { "documentation": "Code for the postal or zip code", "label": "Entity Address, Postal Zip Code", "terseLabel": "Entity Address, Postal Zip Code" } } }, "localname": "EntityAddressPostalZipCode", "nsuri": "http://xbrl.sec.gov/dei/2021", "presentation": [ "http://www.ge.com/role/CoverPage" ], "xbrltype": "normalizedStringItemType" }, "dei_EntityAddressStateOrProvince": { "auth_ref": [], "lang": { "en-us": { "role": { "documentation": "Name of the state or province.", "label": "Entity Address, State or Province", "terseLabel": "Entity Address, State or Province" } } }, "localname": "EntityAddressStateOrProvince", "nsuri": "http://xbrl.sec.gov/dei/2021", "presentation": [ "http://www.ge.com/role/CoverPage" ], "xbrltype": "stateOrProvinceItemType" }, "dei_EntityCentralIndexKey": { "auth_ref": [ "r5" ], "lang": { "en-us": { "role": { "documentation": "A unique 10-digit SEC-issued value to identify entities that have filed disclosures with the SEC. It is commonly abbreviated as CIK.", "label": "Entity Central Index Key", "terseLabel": "Entity Central Index Key" } } }, "localname": "EntityCentralIndexKey", "nsuri": "http://xbrl.sec.gov/dei/2021", "presentation": [ "http://www.ge.com/role/CoverPage" ], "xbrltype": "centralIndexKeyItemType" }, "dei_EntityEmergingGrowthCompany": { "auth_ref": [ "r5" ], "lang": { "en-us": { "role": { "documentation": "Indicate if registrant meets the emerging growth company criteria.", "label": "Entity Emerging Growth Company", "terseLabel": "Entity Emerging Growth Company" } } }, "localname": "EntityEmergingGrowthCompany", "nsuri": "http://xbrl.sec.gov/dei/2021", "presentation": [ "http://www.ge.com/role/CoverPage" ], "xbrltype": "booleanItemType" }, "dei_EntityFileNumber": { "auth_ref": [], "lang": { "en-us": { "role": { "documentation": "Commission file number. The field allows up to 17 characters. The prefix may contain 1-3 digits, the sequence number may contain 1-8 digits, the optional suffix may contain 1-4 characters, and the fields are separated with a hyphen.", "label": "Entity File Number", "terseLabel": "Entity File Number" } } }, "localname": "EntityFileNumber", "nsuri": "http://xbrl.sec.gov/dei/2021", "presentation": [ "http://www.ge.com/role/CoverPage" ], "xbrltype": "fileNumberItemType" }, "dei_EntityIncorporationStateCountryCode": { "auth_ref": [], "lang": { "en-us": { "role": { "documentation": "Two-character EDGAR code representing the state or country of incorporation.", "label": "Entity Incorporation, State or Country Code", "terseLabel": "Entity Incorporation, State or Country Code" } } }, "localname": "EntityIncorporationStateCountryCode", "nsuri": "http://xbrl.sec.gov/dei/2021", "presentation": [ "http://www.ge.com/role/CoverPage" ], "xbrltype": "edgarStateCountryItemType" }, "dei_EntityInformationLineItems": { "auth_ref": [], "lang": { "en-us": { "role": { "documentation": "Line items represent financial concepts included in a table. These concepts are used to disclose reportable information associated with domain members defined in one or many axes to the table.", "label": "Entity Information [Line Items]", "terseLabel": "Entity Information [Line Items]" } } }, "localname": "EntityInformationLineItems", "nsuri": "http://xbrl.sec.gov/dei/2021", "presentation": [ "http://www.ge.com/role/CoverPage" ], "xbrltype": "stringItemType" }, "dei_EntityRegistrantName": { "auth_ref": [ "r5" ], "lang": { "en-us": { "role": { "documentation": "The exact name of the entity filing the report as specified in its charter, which is required by forms filed with the SEC.", "label": "Entity Registrant Name", "terseLabel": "Entity Registrant Name" } } }, "localname": "EntityRegistrantName", "nsuri": "http://xbrl.sec.gov/dei/2021", "presentation": [ "http://www.ge.com/role/CoverPage" ], "xbrltype": "normalizedStringItemType" }, "dei_EntityTaxIdentificationNumber": { "auth_ref": [ "r5" ], "lang": { "en-us": { "role": { "documentation": "The Tax Identification Number (TIN), also known as an Employer Identification Number (EIN), is a unique 9-digit value assigned by the IRS.", "label": "Entity Tax Identification Number", "terseLabel": "Entity Tax Identification Number" } } }, "localname": "EntityTaxIdentificationNumber", "nsuri": "http://xbrl.sec.gov/dei/2021", "presentation": [ "http://www.ge.com/role/CoverPage" ], "xbrltype": "employerIdItemType" }, "dei_LocalPhoneNumber": { "auth_ref": [], "lang": { "en-us": { "role": { "documentation": "Local phone number for entity.", "label": "Local Phone Number", "terseLabel": "Local Phone Number" } } }, "localname": "LocalPhoneNumber", "nsuri": "http://xbrl.sec.gov/dei/2021", "presentation": [ "http://www.ge.com/role/CoverPage" ], "xbrltype": "normalizedStringItemType" }, "dei_PreCommencementIssuerTenderOffer": { "auth_ref": [ "r2" ], "lang": { "en-us": { "role": { "documentation": "Boolean flag that is true when the Form 8-K filing is intended to satisfy the filing obligation of the registrant as pre-commencement communications pursuant to Rule 13e-4(c) under the Exchange Act.", "label": "Pre-commencement Issuer Tender Offer", "terseLabel": "Pre-commencement Issuer Tender Offer" } } }, "localname": "PreCommencementIssuerTenderOffer", "nsuri": "http://xbrl.sec.gov/dei/2021", "presentation": [ "http://www.ge.com/role/CoverPage" ], "xbrltype": "booleanItemType" }, "dei_PreCommencementTenderOffer": { "auth_ref": [ "r3" ], "lang": { "en-us": { "role": { "documentation": "Boolean flag that is true when the Form 8-K filing is intended to satisfy the filing obligation of the registrant as pre-commencement communications pursuant to Rule 14d-2(b) under the Exchange Act.", "label": "Pre-commencement Tender Offer", "terseLabel": "Pre-commencement Tender Offer" } } }, "localname": "PreCommencementTenderOffer", "nsuri": "http://xbrl.sec.gov/dei/2021", "presentation": [ "http://www.ge.com/role/CoverPage" ], "xbrltype": "booleanItemType" }, "dei_Security12bTitle": { "auth_ref": [ "r0" ], "lang": { "en-us": { "role": { "documentation": "Title of a 12(b) registered security.", "label": "Title of 12(b) Security", "terseLabel": "Title of 12(b) Security" } } }, "localname": "Security12bTitle", "nsuri": "http://xbrl.sec.gov/dei/2021", "presentation": [ "http://www.ge.com/role/CoverPage" ], "xbrltype": "securityTitleItemType" }, "dei_SecurityExchangeName": { "auth_ref": [ "r1" ], "lang": { "en-us": { "role": { "documentation": "Name of the Exchange on which a security is registered.", "label": "Security Exchange Name", "terseLabel": "Security Exchange Name" } } }, "localname": "SecurityExchangeName", "nsuri": "http://xbrl.sec.gov/dei/2021", "presentation": [ "http://www.ge.com/role/CoverPage" ], "xbrltype": "edgarExchangeCodeItemType" }, "dei_SolicitingMaterial": { "auth_ref": [ "r4" ], "lang": { "en-us": { "role": { "documentation": "Boolean flag that is true when the Form 8-K filing is intended to satisfy the filing obligation of the registrant as soliciting material pursuant to Rule 14a-12 under the Exchange Act.", "label": "Soliciting Material", "terseLabel": "Soliciting Material" } } }, "localname": "SolicitingMaterial", "nsuri": "http://xbrl.sec.gov/dei/2021", "presentation": [ "http://www.ge.com/role/CoverPage" ], "xbrltype": "booleanItemType" }, "dei_TradingSymbol": { "auth_ref": [], "lang": { "en-us": { "role": { "documentation": "Trading symbol of an instrument as listed on an exchange.", "label": "Trading Symbol", "terseLabel": "Trading Symbol" } } }, "localname": "TradingSymbol", "nsuri": "http://xbrl.sec.gov/dei/2021", "presentation": [ "http://www.ge.com/role/CoverPage" ], "xbrltype": "tradingSymbolItemType" }, "dei_WrittenCommunications": { "auth_ref": [ "r6" ], "lang": { "en-us": { "role": { "documentation": "Boolean flag that is true when the Form 8-K filing is intended to satisfy the filing obligation of the registrant as written communications pursuant to Rule 425 under the Securities Act.", "label": "Written Communications", "terseLabel": "Written Communications" } } }, "localname": "WrittenCommunications", "nsuri": "http://xbrl.sec.gov/dei/2021", "presentation": [ "http://www.ge.com/role/CoverPage" ], "xbrltype": "booleanItemType" }, "ge_A0.375NotesDue2022Member": { "auth_ref": [], "lang": { "en-us": { "role": { "documentation": "0.375% Notes Due 2022 [Member]", "label": "0.375% Notes Due 2022 [Member]", "terseLabel": "0.375% Notes Due 2022 [Member]" } } }, "localname": "A0.375NotesDue2022Member", "nsuri": "http://www.ge.com/20210923", "presentation": [ "http://www.ge.com/role/CoverPage" ], "xbrltype": "domainItemType" }, "ge_A0.875NotesDue2025Member": { "auth_ref": [], "lang": { "en-us": { "role": { "documentation": "0.875% Notes Due 2025 [Member]", "label": "0.875% Notes Due 2025 [Member]", "terseLabel": "0.875% Notes Due 2025 [Member]" } } }, "localname": "A0.875NotesDue2025Member", "nsuri": "http://www.ge.com/20210923", "presentation": [ "http://www.ge.com/role/CoverPage" ], "xbrltype": "domainItemType" }, "ge_A1.250NotesDue2023Member": { "auth_ref": [], "lang": { "en-us": { "role": { "documentation": "1.250% Notes Due 2023 [Member]", "label": "1.250% Notes Due 2023 [Member]", "terseLabel": "1.250% Notes Due 2023 [Member]" } } }, "localname": "A1.250NotesDue2023Member", "nsuri": "http://www.ge.com/20210923", "presentation": [ "http://www.ge.com/role/CoverPage" ], "xbrltype": "domainItemType" }, "ge_A1.500NotesDue2029Member": { "auth_ref": [], "lang": { "en-us": { "role": { "documentation": "1.500% Notes Due 2029 [Member]", "label": "1.500% Notes Due 2029 [Member]", "terseLabel": "1.500% Notes Due 2029 [Member]" } } }, "localname": "A1.500NotesDue2029Member", "nsuri": "http://www.ge.com/20210923", "presentation": [ "http://www.ge.com/role/CoverPage" ], "xbrltype": "domainItemType" }, "ge_A1.875NotesDue2027Member": { "auth_ref": [], "lang": { "en-us": { "role": { "documentation": "1.875% Notes Due 2027 [Member]", "label": "1.875% Notes Due 2027 [Member]", "terseLabel": "1.875% Notes Due 2027 [Member]" } } }, "localname": "A1.875NotesDue2027Member", "nsuri": "http://www.ge.com/20210923", "presentation": [ "http://www.ge.com/role/CoverPage" ], "xbrltype": "domainItemType" }, "ge_A2.125NotesDue2037Member": { "auth_ref": [], "lang": { "en-us": { "role": { "documentation": "2.125% Notes Due 2037 [Member]", "label": "2.125% Notes Due 2037 [Member]", "terseLabel": "2.125% Notes Due 2037 [Member]" } } }, "localname": "A2.125NotesDue2037Member", "nsuri": "http://www.ge.com/20210923", "presentation": [ "http://www.ge.com/role/CoverPage" ], "xbrltype": "domainItemType" }, "ge_A7.5GuaranteedSubordinatedNotesDue2035Member": { "auth_ref": [], "lang": { "en-us": { "role": { "documentation": "7.5% Guaranteed Subordinated Notes Due 2035 [Member]", "label": "7.5% Guaranteed Subordinated Notes Due 2035 [Member]", "terseLabel": "7.5% Guaranteed Subordinated Notes Due 2035 [Member]" } } }, "localname": "A7.5GuaranteedSubordinatedNotesDue2035Member", "nsuri": "http://www.ge.com/20210923", "presentation": [ "http://www.ge.com/role/CoverPage" ], "xbrltype": "domainItemType" }, "us-gaap_ClassOfStockDomain": { "auth_ref": [], "lang": { "en-us": { "role": { "label": "Class of Stock [Domain]", "terseLabel": "Class of Stock [Domain]" } } }, "localname": "ClassOfStockDomain", "nsuri": "http://fasb.org/us-gaap/2021-01-31", "presentation": [ "http://www.ge.com/role/CoverPage" ], "xbrltype": "domainItemType" }, "us-gaap_CommonStockMember": { "auth_ref": [], "lang": { "en-us": { "role": { "label": "Common Stock [Member]", "terseLabel": "Common Stock [Member]" } } }, "localname": "CommonStockMember", "nsuri": "http://fasb.org/us-gaap/2021-01-31", "presentation": [ "http://www.ge.com/role/CoverPage" ], "xbrltype": "domainItemType" }, "us-gaap_StatementClassOfStockAxis": { "auth_ref": [], "lang": { "en-us": { "role": { "label": "Class of Stock [Axis]", "terseLabel": "Class of Stock [Axis]" } } }, "localname": "StatementClassOfStockAxis", "nsuri": "http://fasb.org/us-gaap/2021-01-31", "presentation": [ "http://www.ge.com/role/CoverPage" ], "xbrltype": "stringItemType" } }, "unitCount": 0 } }, "std_ref": { "r0": { "Name": "Exchange Act", "Number": "240", "Publisher": "SEC", "Section": "12", "Subsection": "b" }, "r1": { "Name": "Exchange Act", "Number": "240", "Publisher": "SEC", "Section": "12", "Subsection": "d1-1" }, "r2": { "Name": "Exchange Act", "Number": "240", "Publisher": "SEC", "Section": "13e", "Subsection": "4c" }, "r3": { "Name": "Exchange Act", "Number": "240", "Publisher": "SEC", "Section": "14d", "Subsection": "2b" }, "r4": { "Name": "Exchange Act", "Number": "240", "Publisher": "SEC", "Section": "14a", "Subsection": "12" }, "r5": { "Name": "Regulation 12B", "Number": "240", "Publisher": "SEC", "Section": "12", "Subsection": "b-2" }, "r6": { "Name": "Securities Act", "Number": "230", "Publisher": "SEC", "Section": "425" } }, "version": "2.1" } ZIP 15 0000040545-21-000058-xbrl.zip IDEA: XBRL DOCUMENT begin 644 0000040545-21-000058-xbrl.zip M4$L#!!0 ( "5"-U/")(O7*1( =2 / 8FMM961I8V%L<'(N:'1M M[5Q;=]LXDG[?7X%Q>GLZLQ*MFR^Q,SDG<9Q.)M>-/9O33WL@$I30I@@U 5I1 M__K]J@!2I"PYV73BV'TZ#XY%XE*HZU=5D!_^[>G;D_-?WIV*J9MEXMV_G[QZ M<2)VNKN['X8GN[M/SY^*Y^>O7XE1U.N+\T+F5CMM?0?#__6[8JG)BYG*GZ==IAY5ZSS< M]9\?[O(F#\#P8-!/-Q/AKTX[0WW M]N/>__9!Y"Z&^SG6+3/USYV9SKM31?L?'0SF[GBA$S<]ZO=Z_[G3'B>+"8:. MC7-F=M2+>H<8[-1'UY69GN1'? 1,20T.'.;$)C/%T;T>_SNF-]U4SG2V//K[ M"6:-"_WWC@6[NU85.O4#K/Y='?7[6)P_+@)IF)_I7%6D]@=[H._TXU2/M1,/ M'D3]A[LTOCI@?)\DA=OU\*IXKF;EI+ LEG!&/X]]*C5^? MO!2O5:)CF77$Z<>YS!/2@W]GKI#6E'DBWIG"I2;31N@<\\Y*\!JCQ?]H6X)1 MOTO21]$^8D,VYHN%\)1N<)M.:HVX>H/E\RYWJFK'BC%N*]F/*\J_JBQXG2/MP*#XDZ0]H4MYW,(Q8J64.DX_8-C*WX8BK'.,AK9$..8#%Q9&X8)1;*V-"@MS$PD M6DYR8YV.K9>SK>0,C1!NJ@HY5R5>TUM57((LS+5_B?VKBYW]L14QQ*\@11AC M7%KX-54(DZ;8&D]()C*.50:QT.#-BC IS,)-(3 Q+U2L6=A3'O:7N7YUN3U. M$@A-SB5L3[LE<3V5UG5)""RRY%+F,0)M;5B7+0=JU81L_<=[>P^.A72PV]CI M2]7UL:TV7XPK+GF]&)&;1G3$%*1U@[##,E<-TW,,@;EXM.7=S02B)V_/SM^^ M$:RD_6-QIN9.S<90[L&PXU%&]>J;2/I:%8,9_?3FE[-3".'P^.?3^V(JK5#D M[R W]HHR%W)2*';+%$7EAB@J108(A!-!;)^0>L<[W\<9?+RVXD3.20?%.UFX M7!56I*; "-P1G!0 MY[FYE,XPAR:9&=.;'!IOYN3/H--"S^2D!;Z4%4R& 2:D3)6+L MJF,-(D52LH<$=,0:64:&>"DMK4EK%08@$4&,UL1IE/7AS=1B42)1:BZ$': ' ;I5/Y43E8J%AU#-#F&T*UNWO]80"+C!+%6C'4HG*<#ZF M-#'E.%/=1$\ /0N%,(U3>-<0W5H%:6/3=V"SIFCC67'Z5KS44(M,AQ.+%0"&9P@N-29R#!M2,65LE #(F)F1[T.BT=G)Y $*R,B#9J MJZKG5@2?-1M#@[ US832J@).5)%G^__Y=J]KFQ$MVS ,5.43-_6*&N*'UR($ MQ@7B80,;,S4S>/-@KLP@Q>>P#O/IM#@7'T7G*WI:UA.)M^U5R&:]S\=;4'4! MDRW@$FAF95PVE%0\CEN=FBH2%O( F=>==&TS>#X;S).W8SO3.;D[E33VY) P M@\)N#5#>\PXGI6AC=4)*:B,U17F1VQ)M=GU<@-/NKHR@07"=-! <8?7U-3F*8BI/NLYT%9MY2/[<%.Y@,O5D MES3<1XMR5FER\*W-Q)Z"SFH>@L12K*)*M&;3:V'13ODA],GKY"IA*//X -B[3Q*@[:3!C87#2[&*3G["KHVEO$%I =V=H/:I?SO^-LJX95@ MCH_D^N)P[B#(2YDAEH^!3LHB!#COPA0[S*8KUGF8 !L7HY_9=K(H"XU;&>\9$(1 MA-0E&7ZA)F5&*3/LN7134W"T^",IW7>2R"E4/2;L(ME'4GWE(SP>)^@I?$'. M3DHF,$Q3^%A*FKDF-6BX'EL*.4_+/.3,!5 .^=9ZX4Q-UI>*Q+^B=Y%XS1A: MG*FX](P4KUZ=<&6MFBF3J]1TZGD CIE: D4,#X\!?*.UZ1MF$H6OD';*F?@@ M'5P';?F.'Y_%4YVFXCF0*!2"GVX]PFV3]G4K-M.8?/GM%A5J2>J.T;PN>C*%'[Y M2&:4T.]\4?=P2Z-P*S&?P^N;J:4^\^E:EW(WBD;(:)RZKOQ[,WZ-L452-Y@Q M7I+"!]"=;B4ZP," 7CEMU52YJ =X4.ZAE<]-.R(WCH"IZPB*G(XK+$@%Q?9M M #6A"QEM7VSG&UN8,]$[ ARJZ:V]P2%\2ZH24G'8()R?4 MDU@X^9CC.;S&Z-AOV.'?_1-X>>1W2-E4\RG!D3QI/@'ZRIN?QX /.'GSD57J M8NUS\R.AFM9G4V:M+8 !@+3:A.#<*B8V-YXY6+)J/4&VDVFJB!;+\!A^BW\I M*.V._+/M:AOBGBX$4"&7'H*00(XC;,E*(4GNA)PTI42D8XFBHCQTI81H"F*Z MEP.AGV9PU?:B.FO]$@BNJLBXY-;80?CL'$C?% 5I 3E\H%!HMRTS1ZLMD3(@U%?+(@?E M7 Z!GRLJ% %(6ZD[4*M-0LQC)=NN^FPP 73SC(8$ NED5F,"(!.LY*.1 M%'6Q+F2Z) R>3TH)QE:*PQSR*B[]D1E)CRGJ3TE;D7&^F%$/F[!-BN.;2K8Q M[Q[+TJIUMM02O\*7SZ/!IU80D)P9*E-1)H8)/_7O^ZV; B=(R*W7RJYY^S44 MTLS6@C:T@-J\5ISI"++YBLN$_);'5=U/>$ M*^[XCN=/@_L>\<+ _"&WD=%DIB_+.]] H0FKY)LJ-&DA9]X@B6E9%K8:WF^8 M[[(Z\BH&;/3WZ_DIK=I(Y%)#::)7&:;ID\PT5#376>FOXU!9B;I/-+YETSZ] MM]>M%7K&\&,_C>Y[M?%\K"Q+4H\(I\WH=.Q(B#NDT/0_6->H',#&^6Y)RJ/K M,L/9Z4E3#1L39)Y[*Z5YI,G/N 73[W5?=HB#VH!#(K2ZLF6]01A) _^[,1"0 MG%WZ^K##[DL?6OEX%;K81*=WU.XRGL4E%)'A*BY@2KE_25HM"Z,,4%(M>SRC=S M([0_V./2!+P/-J ^/14O5+B;=$ZW2%#8- C.L0RA)CK.PHI6IH@Y* MLVJL#'P(PY>$BD/6X\V:1G@/7TD&@;7J4V6'>DD9 FSFCTXM4 H-#%9A,M8C MYRRE<-S8K^HV^$U"1X_Z\S"PNK 7";IE"A0'UOU)#:55?X2Z;BMY?8\6!U?P ME?BA?U#=^?A'Z(/RZSIE\8%J97+X=#\2CVVXET(J$W1X5A4A&RH^GTH$O)A; MR-3,:K2;63FH8DA59,KQ0WP/ESDZZ]7.4%!N-):A?-R\:C6+-S2QJM(W*3!. M.O$0_U+'!/$3Z21HD=F2J.H0D,C(*NKV%]^0XJ'AHJ2'QJ3+IXFV)F^LB\!> ME;,C\8$LB8 58E+/>Q?B9H/)E3/Q_4VMJD0PE+A'!QWH0>."AFR#?"U[O?'2\,_3N-6='881_$7?Z"BFH M#$E)!?S*#U3=P:HKR(9>=>4[G)SHA)%QN"OHR;&A*V;!%JJS7:WK?\MJ9#\9 M# :'7]W"GC%J$R7!C!_O]?=[&Z\7?KI4.I3C^"L3Y^]=PB9,P;I]Y)-)C +9 M,- QDKLO(?8;<;)SA]CW2N<7*GF1_\6^+V+?.1 '_-5MXA[YICO$P1?A M4M M8J'G7E42H"HKD&2N%I83U4OZZ@%72A=JC%_5'6*V!ZVK -F$K[>*\0TTQ(>X M3?'TP1?=E-]Y](_3CU7)X(DV[QA.&>DM !"IRK*ZAU3?JN++HT4PJ/ID&R,&FE& MZ\KD]?QLIQ-3V=(.ZZBBDE =F0L@C9K)B-.3QI(5;VWK=GI#<-I6-Z"I\(B, MQ]]_]O>-/P;6(6$%$3ZZ')G@LGX(B3. MVR+)MW4+7Q(6_FK]?[76_PV#ANOB5/C:T'<-4M57EZIO]M %,F[[I[J8^9HC M7$1=88 M+MT2$)! A+F#3FW_CO>-T;Q9"/]2>:[I.L S\_&VTOA??3'JC\3>L">&O<'! M'R?SIJVM8G+T/@*;?[RW/SJ^XQV@S8)Z+O-<3L7SDCITMY7(EI7>/5WR/(ZF MS.,_I$HW9+RCD3@X/#P0AX/1H->_LQJ_Y8OXJX2OY>^_/[W;W#V0E!3OY:TU MS\.]@^C!@[WH8#1ZL\]=">J/'O0%(VU@WENN[V=. >NW\&6+-5W^^$_U1W=/XV?@\P78'.7J4N<;]/[F&"E\Y\O_W)Y/MVN&UQ8, M[U9)<]?_B43^8XV/_@]02P,$% @ )4(W4\M;O;UL'@ .O \ !G M92TR,#(Q,#DR,RYH=&WM7>M7VSJV_SY_A6_FS@Q="P6]_*(]W,6!E.&<)K20 ME@E?NB1+)@8GSM@.$/[ZNR4G$!)HH27E<=(/)8GUW,_?WI*E=_]WT4N=,YT7 M2=;_K4;JN.;\W\:[_T'H/[_O?W"VLVC8T_W2V+MA'>KJ\ MNJXP7=A;JQY>%87AG=YH^IS9LB0,PS7[=%+T6-\H=ZSK4=:SH\4A9>-2=S=E M*#9I:J[3F_,QCZ4HKN:37)2HT-&-&O"]?IR=31%XK&!I M: NNIZ)__%M-]]'G@QH(F19JXUU/E\(Q59'^[S Y^ZVVE?5+4!W4'@V@_:CZ M]ENMU!?EFJ7RVL;?_O:W=V52IGKC6*,)B]ZM53^]6ZL:EID:;;Q3R9E3E*,4 MN*N28I"*T7H_ZVOH/KE8-P5U7GU,E-)]^Q&>MT![\R2J>K\H]W7\6RUAU->! M*R,?^-'.)[>UTR!' M)Y]HI_?)[5SNTKW#_>1H.TV:)\>7S7;#_7-R\;%WI< ?Z!'H\YAY'7:W9/.Y>]0IP%M1Q>M M[?T3TTZGU[QL7GZZ..I!^>W.J+7]^4SMO$_DSF>ON:V25F_7;9T;AY,Z7Z OMW_4SLY;=)=V3D[IWO8GWJ*?\='V M40+E6:?]>]ILMY+697H"\[TX^A*,/K0;9?, 7\!?W&QO7GYE 5.14@R!X=*( M!V#B1* E\MT8[!P5.J:\MH'-/XY=[KY;N\'41?)X$XR^,H;_?2J.E[S]'F_) M'&_!3P68^@HI-_ 0EU$,KDX%P&K&-78E]6-H+U$BS.;[4BZ0U28]GL;]W5,K M9BMO3'ZZV?H J)NIR3>P^WFY#9AFHW+D(3*6=_;9U3#5'44G3R;?)YVLW2#4 MK71S-9/$UV&L0L)U$ FM XE5Q#3@),W8$]!M/'U];%2_^JJ@LXM!FD1)V=0] M"5VH!)Y6<'&,A=8/2J"!J;.5BJ+8BP_*+#K=O$B*VL:DR%;6ZV5]^Z!JY]W: MKYJ%"^"F5@!)R/!(ADH +(TI %6(0!3GWC$P_QU,/-8KV_B.O/=5E;J M8GNH82[T-;(S##P&L43 ?!UQ'H)UBY7R,?4(]27V@M?#3E*G+IYB)WN-[ 1F M^BJ@U/48X\H#%^6ZA$4,*RIY%+FOAYVX'MS03OHV"7<(^(I$,?"M/,F._W7R$X68 \PI'9U"%P-O$"&5+DD%$&,8\G#U\1. M%T\;V_ ULC,63&C.N60LXHP0Z<9NY',J,3A1&?JOAYU^W=T9BES Y+4Z&,HL M5TG?I$FO6IP%6?N![GH>%!Q0/91@'//9W"PN]=ZNBF$]YJ!!R=S)(EZU$/&4N=R+22[W:*=#.X=?NIW+;G>O_8FU MMM.3HT,HTS[J-2^_0'N?SH\.6Z='.\TSM?.%JW__D1[1]$R>#$Z/3HZZ1X?O M3_9V&FYK.\)[AS .&$^KU[ELF;%O_YYVZ/YIAP2L=;G[E6$M 8E0I(CR$ \C MAD0<HEH)7ML(T)^SB5CGM0H# %W.67F'.C(K $ZA#E9[A!W1;UQLMAI=[5Y-,R3 M,H&.&Q=15_2/M;,9E>8Q"1E_0D;-3I/?.DWCT,U@]_4@RTMG9?)="W#INB@= M?686YW/[6,.\']V*5$NL4/NB7%?0.^I!DUUC6Y 2(S2"D2#=O\W:?+3XHU&A MDK^6V1DU3SY_#9@,&-4,81YHQ%TF4!C3&#$I:.02GV(2@K/6@[+"II2MVET3 M\\M!+\T(W4>%*TNB=)3E=@5_?=@'"&I*U1:_=KVOCY/"[" H6_#DKR6;X!*; M7WV7>0&1# 5>+$ VA5V=C) ,0JDC)D+IX]K&CN[K7*1.(P4+:SBQE9E$(AUW8ONK'H_#*Y>1.@9BF(XAD"O5I.=Q]%6OGJV5ZI:'-*Q3]QO/OUGY M6P^97_<7TC"G"QHQ6=" "0DF_'DA(P[QW];J>WBX_:$6E=;E(8XV7GY#/O7#;F]D(=]3[3YDGKI+6]Z;;:,$9XWCG9 M3UN7GUES^^@$GB6M=O>D:<;8WKRY%RJ6TA512)$(0H9XY!,4X"!"H!0QP90J MK@$)&_GI9/GIG?AW;"VN-(#-J3PV"E^[5]%G91U^D2;,"OK[)-70.@0?2ZF^ MAU1_NBG5GD>43["/7#< #$T]@@2A$G$OE&$8<^H+:A8M" (Q8?.;-Q]!K+T? M\@%_=;%OBXO=\<)19&W\4@?NK0.=FSJ A1;4TS[2DA#$I0I1$+L:A8QI$1#& M8A[4-@A'V /3S_$WE>!VZ$/)]Z&/B<,>0>8K[7DB++ABD8;)8&9E5^?.R3!/ M"I78U*9-Z%1@$:+79!J?O'E<]_B:"&IVG"9%<9-^QN+=-)M.*ZN_^=G@Y1N$274\G_EX3K':(L'HLM^+B7 W?[2ZF^AU3/ MO&,7$-_52O@08(>QB;L#%$@1HI#0(/2H)P,:U39^SPJSCV@ISHL79QO"[.4? M\^PLL2]5+V7ZNS*]>U.FE1LQBF,?!:[O0D3-- HTUDCY@@BI@ -"UC::FT^6 M)7U-V&R92WLDQ?$-E:D1\E@N41R3[6?2:0)WU/E+=X.E.P,I9%L\%CD(/_208B=?2%CH9E5K$!VP7(XQ7=&@XX8A<"^#4E)UZBKWWSM-U_JU=PRL+ M!+LF3[,)Q'^Q\/9GM@MO?A7*]K.TSOS[M3J.#!$.3]TK\^'YKF66I%* 3)6CFM/\^S),2U-!LTQGVQWM*BA?IQ*OD8:O7ZC8O-WGK M\GC4Z>WW6MO[IT?MX]'1]BXS2<7F3F?4:1\EG0A[=#&97/[F.UM_Y% MW[BULY_"Y]/F242;)\WSHY,_NC#N;B<-SN=6=P,2:X^)$$54",1UJ)%T!4=* M":Z)CX4?4A,EA3[G;W]BX6!!XORHL>!8J& :TU+E#*;>%]X?@NGDU!V;[O+F M>\+F]> 5XCM;[_<=RG ="OYPRG!I)A[!3!QD]H 5(%03W+N9T])&?,]&W/(. M1@0F@6B!* DYXD*9=S"X1('FDK+(PTS*OXJ-N)8HIS<6J7D#0;A A$[9B!L' M"%Q9" ZPP)9\\RC;Q):FXF=,Q<=<&S1A#BZVYYT8C)_OQ?$+S0W\4I,QFC,9 M5$:1#%PP&:[G(8Y#%X6!)Y$YVMJS+471Z[ M4BU-R%TFA&G$5Z+[F9!QV9\S(7,+9C^0#_2 &%/I*N\AV4%K27[4?%1GWUT' M'=V[(Z?X_))#U.[G:MOFEJ'J-+&H MZT3F^-.9\SB_NS5Z2<]I>N;"KM(?C'HR2U>*-X]+S;SJ:DEL2^S6^"@G*[MZ MXA;!KI]W$_CEVOC?PH2EK7A46/XC]]A,Y_\=_A'K]5N MG'=Z7Y+6]B?6N3PV-T;U6B=?TJ,3*'_RF;8.FW,X^V@;QM'KD&;[]^3HW MMM7)WK;J C:'\E]Z30JXO=TA'7)+=L^3F'F:"11YU$=<21\)%0@D?7AB0J,X MIK6-Z@H>D)PL.EUU!B)WSD0ZU,[_XCHFSL QZ2[#V;#3J1VZ<7X*UG]"8^4,O ^KS,/ ETA&H#8]C@-LE)DNP]E =F0%K1D-TA#%H1BP19V& M1.QQJC%D M'JMIGZG QXA+\Z*(%[A(:!8@CPKFX2!F?FP3:_-8;>[,H256>YYJLL1J#]61 MV550C+G/-4=$$8TX91A)Z<;FQJ784X'T7%]46,U?)M9>LLXLP=I"U6H&K)%( M!LP+/!2Z 81 P"8DS95FL?1XX'(NL'G->0G6GHE&L0![U-?:U2$H5N %,J3* M):$(8AQ+'B[!VB-K#)T#:P)'*M Q0R00,80WC*. A P%$8M<-W9YC(D!:RZ> M704-EV#M9:C)$JP]5$=FP%JH-/8\K9#/J4(\C@(4:BI1'%,=A4)0U]RX9,#: M@G5BB=46JC)+K+90K9K%:D+[(>>@1J$Y\$"!TPF93Q$'8!?%5,8T%DNL]FPT M*A9,: [\8BSBC!"(5MT(#*+$4:QDZ"^QVB-K#)O?L>;AD DF44A=%S0&*_.B M@8O<.-1FWP!@-%7;\!VR1O_A[ R%.=-6:^4<#(TX)WU1PI=I#/>-F\R7&.Y9 MJ<\2PSU4=QJSES)QJD,5(H^96S.ESY'T@Q!IKC$+":5AY%D,M[9HI5B"N(7J MS!+$+52M9D <%U@%$=6(Q"X'EQ0H)$// P\%I4-!?Z M;XI;^8'O>1XVFZO<4(9FB[SGZD!ZH&"4+D'>(VL4GP-YC-*(4DY F72(>$!] M%'K@K3 06_ @EJ'BM0U:)W1F]93]].KI4HV>AQHMP=Y#=6@&[$F)%<&J=66+!A:K4$@LN5.MFWVK 4H<\\%$D.(18 MH7E9B 0>PI3+F.A(Z$C^-!9\T#V S^DDS^7-.O&J$'HC\UYD\=Y=EYVS7'" W,-E0!PIV/H M0CE)?WS9"78G)]W.W'0"OY*0,6?%W%[@O[47GDP*0S>@9P-0BS?FTK'J3&(J M$;VEK1L'$U>-\DFCU<4(]I3BZ]I3C=<7?.SYS\F*=;?/2E@:MS/^Z8_+?B4' MP5@3N M'WZ;<_&M[:9Y#I#@U%QSCZ$-MM<^OFS13Y>=]F>8YU$*[IS9,A3XLM"T%LQ]?AP@EB\2>CSZ T6;*:(WM*QV9SL\3Z-HXF3[,#9[D M^BPIH!ZX&]&/C/:+*,J&?7NW3E&*OA*Y*FX_?YVMB*OSUZ?=QT/2 M/2O)=\+2<75N$.0@J_BQGNM4E,F9'@/'L9&.=*HI8]01R$$NHG*]&/9 #48+5]FY2ZJ) M.:Y^M]0])S"'ZNY9_-8X@^BBJ-^?XKI5.ZN]/B@O M(#9SU[)#V:K9T$=6KVXU;1C;8ESUV%<"3"V&8!N$,S"WU(*M2+4 @R/Z?; 0 MD;$0UO;TRWQD+F3-C)D3Q[FN;LCL$VPB/';!&0U#Y2WNEQJH3YUG/V4Q+D0/PH@+ M:]J$$XFB:PP4&" 8W F8,\5_U]2YZXCDS2%ENI.&T8Z@(H&Z^J+ 363R+5 M^7;!7U%OKN;RPJL M_MK\"GB2.JZ\R4.O2B%NG0:+2(7@\/'S-GY89^0I[BZN,L6_7I2K<2D=9;DU M]NOVDB13ZEK(6]D/IQ9>+6VV=1'ER<#\?%ML-0-!QY>[/QKA?K3H(F3V%WC. MVVWP.W$K9-65U+Y](AF!H%O7G&YN$BSRM%?AK4%>[Y80.!EW\6Y-W'^EZ_4I ME;W [1K&KCK*;HV<1\03W M8[RYH_"-9C6=/'H+Y7]+:UC9,29[-1!%N>KH*K VX1D$7G=W WC67 H/ F5U M.!OFXRC.Y*YLJXX<%C"KHHIQC-WSC.3 M]RJ&4== ZEK5V6K-J4'4ET3) 9FOD'8J_O*? *TVS=_I4X3F)7Y6&A].OYK M_IQ#+&K_9L/45M& MWOCAF",.C(D@<\0[AYK^PD"[S3IP8CS$7R%<+>6FRQ; MO6;D\"Y253%JDCM]80DS(9J55@B;+9.$X0.P1"7F:E3#%!.( M4-$%2MX(A)/B=+J0C:AM.;":/8M+@)\'73-)4!AM1MV#R8TSA8@8II]->!O9WB-ALL,S9+GB^!Q=[C<&.VT%#!*]#*B2F>P85%@A;ZJN MIQENDBF&=%=Z9KN?R;JLCINT!2MIN)%4&1A&BQ3Z,!P=4[2 T11Q4G'O7"1 MC%5CG(4#X]8P(RF*Q [>#O \,>[^NI]* 9QC8_'[AF- (&W7C&PGT*,%3ZAL>RP,X)A0W13MCQ/O-H=?6:8)==XZ*_1-E9D"Y:HF>-<0I@EI M%P;TV(=5"PECHVH("8(A>I4R&H*E*73#WDRI[6@RU6M;?*O=A5([#>??6J1E M-S+V!%J\S@D"$=,T.Z]$Q8[GNT2$^K%(4F/=;&[.6@U;_H8N WJ+$^L\[FSK MK;5=*_Q-)2H5_2;:9%?B8::IF9DU'H8J1HC-7R#93L,Z/O_M)-%2 5,:V)H6O:D*HM^O-',:6A0.P09<5(LW #C_.Q1Y:0S@50<3$ (%/TT5C,90 M9;888)7*O=GI33S\;>.L#)MQ1,>9&6N:%#:/E,Q9&= M(T#ZPMK ,WUW>FF, M,7RZJ)60;RT>S.2;+!):^*ZW[^,M9M(\H*]W+]P\X2+,XNE#[K4"<["[T]IL M?]YO'#QE3G9VK+??65WMCWG^X_PXM8I;K6)8-S0!V/?9$K1ZVZ*T&H)YLG!# M32>=33?&6FE4DV]QX->428,ZCY:Y_ MMM[4K>'N$UP:_A.I<,KJ(;[[\0]?[QW6N>L^?K.LSOB]F[TE\3"AN$V)+6SO MRBZYD3^QO[Y_&/[9]_"DZL[%\9US<_1_W9I0#W>2P%/+H4 M/7N6;D,TLGY+HOG595OO1XZU8LUI)H M=.K\47?^#5,I9Q:SEI;F%_#A%AX8 M^'.@^PG$UU_,/AJS8I*8C4O7NX2VLF&_@%HFI@2PF$-\G/^4FWA8=GP96'XO ML&3?""S79*9&\*=;]M*-_P=02P,$% @ )4(W4Y1C53&, P F@\ \ M !G92TR,#(Q,#DR,RYXGS*%$OMF,AAL&#S!@D7R>XSUWI]/=O%DWM?,,0E+. M4C?PL.L RWE!696ZGQ_?HFOWS>+JZN8GA+[^^G#OW/&\:X IYU8 45 X*ZJ6 MSI<"Y)-3"MXX7[AXHL\$H84EW?+VNZ#54CDA#H/#4Y' ]!K'$QRC+"(1BB=A MB+(23]$\CO&LC*<0 /ZY2H+)M(1)A/5^4:!8FT)D-ILB',]F>8[#>#X-K=&U M3&2^A(8X6AB3R5JF[E*I-O']U6KEK2*/B\H/,0[\KQ_N/UFHN\76E#T-T.M, MU#T^\LUQ1B3T\ H&X J\G#>^D8GG8=2CC WZBE7*I"(L_\MJH012WUN0QSGZ MV#?'YAZ,<(#"P'6(4H)FG8*W7#1W4)*N5JG;L3\Z4M.20J&36H-)VP"P=ZR( MJ$!]) W(EN2O"UM<.8Z),VU:+I3#7I!*(C/K;"=114AKJ<;72/NZR'ZH][LI3V8S^?^VN3QN!]'$V3QR#RB(#SO MVE.9_O&[]0KUO'_#AUT-G^=#S_N'/ARMWE,5,<:T:_F#;EA#$G*OXL]^ =16 MUD@U'L+-@ZV_X9V$,:XLW^QL]]J6LI)O-O26B5_2!_$!RKXYO&@Y1RK5_B5$ MY(+7(V7MMX*W(!0%N=^NK(&E@#)U*T#]B_RM)IFG_>@!+\P/Z\ <^YH"]?U. M1\\UJ4A=J<-?PR8RERN[%7"N;$V1NGO:)/_/U1=0GJM>4RBC?T.[83_J^$.VMOK+>Y<66#]#=<_!^UF$N18IF.H-_XA MXIK(I!(D MUP."$IW.EFFFJ7N>#49KW2I,:6ULV"DHT55*>?%H*Z;HA'59]^!.7TA59U;O M!._:U-W J8)&CR8;>#\6)05O"&7O]9DQM&O#AYH#;X+QSK=P/J+O)/X"M(1> M$$[VXCP;T7(2?P%: B^<[,]6POSN'8.W02?P%:@@/?QFKL M)/X"M& O&O@6CN;E!/X_U6*;^68B75S]"5!+ P04 " E0C=3M04 KZ<) M 71P $P &=E+3(P,C$P.3(S7V1E9BYX;6S=7-MRVS@2?<]7:#6O"PM7 M DB-,Y5U,E.NS4Q2L:=F:E]4N#1D5B311=*Q_??;T"6^B'8R)C.[\HM-T5#W M09]FH[L)^,>?KA;ST6>HF[):'H[9 1V/8!FJ6"YGA^/?3W\F9OS3JQ. MJO/KNIR=M2-..;O_U_HE%(9*127QP@DB%>?$)UH0*R7521; @/YS]I*I(H$2 M%._'2"2*(D[K@E"I=0B42UOPE=!YN?ST,O_PKH$13F[9K#X>CL_:]OSE9')Y M>7EPY>OY057/)IQ2,=F.'F^&7^V,OQ2KTF,P12APL/!._",COX M@!B[I/?'_$46B9#*B'A'I'[BV< M6Y#W$6:1,S@(U6*R G94803^X&;P=5"S_/!R1BT7*]TW7[VE%PDNEV6.&>_P MX^;[6=-?10!7+2PCQ/&HC(?CTFDE W/.%$[+9)E+,3 :G"N,CAB=IS=B,I@M MG'D5[DB=YX!6?6%@[CS,5W>G$9 QRWL&BF+A@CG4U$ M:PZWM=U%?>,6K^LM_LVS M\<2')Z_X@S/75@.8;LT+@A^/JCI"?3BF0U#X >JRBF^7\0TF/]/$DZ6* 1' M,7DQRA'+-1"C*,XVNH++8A N[ZA]-J0^W9B[[+(^[*[G^!%F9=/6;MG^YA8P MC1ZL$YX19KE"/%P3HWTDA5(I60VY[FW*76MZ?VB/TMMK-CW$M MN_HW7$^=<*PP'FL-#3@[;K"PX%A=.$7!6A.4"WX ;N^I?2;D]C'F+KNB#[NO M,8S$'$I^GKO9-!4Q<873\LPZK"4I0A)&$@L86F+2FNE^3^P==7O/YM.-M\NB M[/^,'B]#59]7]6IV)RTN"4?5!7K:]5$58:JYB5%XK/C1RXBD5A#O>, KR3Q7 M+%%F!TG]'@&Q]XP/;>A=/U#]_>#G<@Z_762[3#7C/@FMB2UT3OB\(2;A,B) MQ8(:QI6( Y!^H_&9,/Q$$^[26?2G\]1='4<,,F4JUVVL#3!K6:$X>I>VCA+) M"DZ,HRJO'\HZQ24P,0"W#ZA_)D0/8=Q=UG5_UE_'6$/3;'[EZ;*IB\GZE'!) MX1%!0<3RK?":T&@CA41#9&D QCM4/Q.V^QIUEVDS&--'>/F^/JTNE], WK@8 M--%"H\LE$XG#-)!81J- 1$G"$$OUCN+GQ?(3#;K+L1V,XU6N\+[^4%>?RV7( M_9B@0B[FI,OSM$K@/*,C+G(A*#/"#U)%=6M_7FSW,6U',Z17K^L.L ]5T[KY M?\KS57+(J4)B"2"SDB?>8)%#G0_+2FV!D+Q[O:]Q[+GN9 ML(//7FVM/^JR;6%Y5"T6%\M-9M],HY864SM*C'$NI_)8RJF4B/*8 4;G+&#< M[T-JI]J]9[:_,3OH[=7O.JGF94 C+F>_XJI?EVZ>7VT95AA.@@Y8IJ/G$:,! MKW !8!R89K;?F\U=G7M/;$\S=K#:JWOUH8;L8X#IV^J-97YQ7K]/"6,)"\ Q M5=<$4C!$AB"Q'(^2,"S,'7@NM._7ZWA8]]ZS/)!9.]CNU=RZ!^NX:2Z@O@W. M:@G:.T:BD;E[JC#4<,&(IM0Q':&(5 W)^0Z"Y\9\/Q-W\-^KS74"X0(7EFO& M_6G9SG/^EWA4N=%J:<[A(];G3@@"*A5>1F8Q+^P7P>]IW'M^>YFP@\]>S:S3 MVN4]KR?7"U_-ITD&H:C"O$]Y1B03B"1:2005H)EAWD*_.O>.NKUG\NG&ZZ"Q M5[]JZU-OK\*96\Y@O?V@<)11[PC6:!2G56"NIVV>E@=-9>#6]V.S2^O>D]K; ME!T[.0;H2[U=0#U#9_NEKB[;,UP@SMWR>LJY%-32G,DSB>D>%)C8:T-2HI@D M!*ZI&*+GW*E\[YD>RK =A/??EE5"<^H\K@X\ @L>:W&.@%:OHXDKE".>J?SRS"O&HB'X[:^@)N;U;*%J_;M M?)6='8X;F.6+IQ)^T9"9<^?352<\"SJ:NZ9YGT[:*GQZ?55FFT@6"HP]*D5% M9%2)6(7^F!B 7S7,W6-55'*-7_&ST;3V IBWS?;.RAT(99MC$3]\%=* 3O+( M:84.IWD:P]7WL/2 6S&WP&[C>;.*B-^$:'KOS,2@/K"+:C!_'\K? ME_,-Q<]]NGL9=\#3%3.8OJ8'0JO?JA::-Q> %/ -)*SX)75%(E[F'8AYAXLI MK,+BPWG&5*%%N,?W_>-1CTC?6PJ'LMB CVR&Q ZXHK<@B:U?126LTY(D9PHB MFOU 82>&=%BH$XFC<4 M"J6)=Y[C%2^$+=#%//^6)[%3^EZ3.(3%!CP5L?:KNY#T!I)57%IG- &;7VE' MAND!%)YXEAQPKI@4YEN>Q$[I>TWB$!8;\%#$&I*BMX.#W4 J I56)D%L (;> M) N",Y;$!+WJGC-__TUQ-XF=TO>99;+ M_&\S;F"*;+(%8X(J<7]O71>Q?T'C7I/]O2P[ MX!F(#),?,'XKL(AM8'%):L>D)%1[#"S $S$6$J'46!68Q:E_0U+T@/2])G8( MBSUXI.''R3V3O,./KUYL;NZE$/ M ".E0 $P &=E+3(P,C$P.3(S7VQA8BYX;6S576UOVS@2_MY?H_/KP)?LF2VVNU+(*7N1*%2H-O\^)S\&>J5E\"G6?7P9]9_F7^ M50#PO+KH979SG\^O/A=!%$9P_W_SIXJR$),0 XD$ IA$$9 ZI(!C',8:4P55 M^-/54TBH5@2%YO,T!=B8 B*.*0AQ'"=)&&%.H\KH8K[\\K3\0XJ5"HQSRU7U MSV=GGXOBYNG%Q;=OW\[O9+XXS_*KBR@,T<5V]-EF^-W!^&^H&@TYYQ?5_SX, M7_XD"-9TY-E"?5 Z*/_^X\/KUBGY13GB8JFNRM_L>Y7/ ML_1C(?+BC9!J8=!7UHK[&_7L;#6_OEFH[6>?<&V:P9#77ZA7RW2L[^[# M5(.AGQ[QL;X662$6(WPM'J>I05Z4'[PQ/VVF*0UU!--JGDWHKD%5=X5:IFH= M+7=,!_/TV9GY:7:E9B_@.8O)VZQ0JU]NE5G(XM_5M53Y#"*$8(0AX"J2 /,8 M A9C!A126&BN4L'4K'CX6L_4$OSQ<8N@FJ9WCC,'_XH6G>9JE=WFR>,*=[UH M6K;,BE6N<>QB*:[5ZD9L+C! RV1@C?UY!?/'H (:&*3ENAX'G]9@__OSQ:-K M?I0NQB!J\?_-4;I)PJH,XM1<[4PV. 1)[TT+L9<9%D)CF\*<#.M[),IJV1%YGUKWS-DYGZ M+,CR5.4FZ6]PX^%KF*KY[-6RF!?W+]+4_+Y7)D,Q)5D91RHJ5BHYO\J^7A@3%Z7\RQ^J.%#%@%[#HP0" M6_>VT"FVJ=49,6I28!$D*#"A7 M,8MHPI-4NL6$EIDF&A0,VF 7;K#&ZQH3V@BV#0I'H&V:W MEXH/C(TFW#8WZEIM'>.[;O\Z7ZC-2D)QPJ V27O"(B-/0;E9M"$%(H442T&1 M@L1MJ7XT/C5Y;M::$J#G>EPCSG8)]J-CG%77A@F/=?;0Y0%+:\W8R*OIH1N' M"VC#&#=1EA5[= ZC6L6.MFT>*>.(RC "E"H%,,00L(@K$*HX1DB)2)+0MKO8 M,L?4)%K!W.T"(9_.61NE_=W%(Q!U8O&>FB/[[N(1N!JIN^C)F5-WL8>-]NYB MVX6C=1=[D->[BWU#W5.2/TUJ4ZCER^SZ^G:Y*4-6LR@E4B-"@)8R!1A%*>"B MO+E-$92^4L MS19'2UPZ':IG+]T#W5.8<.^F ]FL)4BD2D<< YUH"##A(>!QF( DY(J:L@-% MW$K&'7-,3^]W[.#0WWMV/5E=V[G^TCW*O5.)S\MNMR,6R4"K]>"O-=?-E M];CT8U-CFT8R#K$*(PXB9!9P#%$"F"(4Q"D.L40A"J'UXYT.\TY-V ;ZC\$C M^*".?K>EYI/#N_Q"^FN?$]%\XE@Q'8;M*Z<3,3U2-754QIUJ+ _>VNLN%V.C MU6(>'M;K,Y_+W=.UE^5C<;D2+[-4S7"<6B1_63V!:< %)3K[[&R'K/Z\S)>"$T=92^^=DK$F5[W2L!U#HR5@ M3?#KJ5?C__LV2%XODRR_R?(JM%?/HK[,;I=%?E]]K52D15S*#V&3<6%M*B9N M\BL@F*"(A1R'VEJ#%O--39J;)L .YMI#TAODCKJUX=VVBW(T-L?II@PBTJ.U M8D7/@!9+M_V16RU6SAZV7.PN&[A!9?/7F_E2P1G2!&F$3!0AD@&SS&L@)=?E MTVXH@I28#Y#7[I3Z+!,-)0\[+38_!"78X-W2=V?*#K&V46,@7>/$"G>F_+>D M-#$Q?#_*CM7OLQFER;'6G2B-@_WS"IWEUU50*0V^+M3U:D82'B+&%4"Z/%B" MXA@(I"F 4L:(1'&,HM0UG3B<9J+2KT$-/E5?Y@JM9<^@AUG[A&$87V/E"8Y4 M>>4&[4P,2@D:S(Z>";2[UI0 =(QVEW]YB,KB_>=LN7TH.XI3$2)(0)1(:6H( MK8#$*0**FP]C;>IX9BWZ?>-3DWJ%+Z@ .C_-?D!-I>] M)'M@;#2AMKE1EV?K&(_&6O95Y2_DJLA%4LQ$"%&LRR,Q(F*689$@P)%9BR&A M:5K>0 D3^\Y:W?+4Y%B!"SYMX3DLM;N$6737?&DX=7O-E@&W!EN3MWX=MAU+ MX[78FAS8Z;$U#G 7WOM9FB0-4I#4H 9KK$$%UEZ?';SVB_4X;)U8N7Y$ M.8'4W@_:[5U6XQVEWZ+XRIM#3WZT)7-7"J&;15^X[EJ0G\ 5Q0HK-7]"Y=_2+V)N'$NK7TWTFHC;YZ:7/7 MTFAR;'2@KL#F 3Y['M#.<\31]E X$8>8(0:DC*J4-P0"\A2D82@2(IC4RJKG MW#''U(18P=Q[-CWR>IZ_F=)NB1Z)J!.+]=0QY&,S5:'L>O#ASW//0R4;7 MGH?F"T?<\]")?'?/0_=0M^AWNP)70MS,RD2FO)&7)5\V7T*%XUAQHD#,N 98 MQ10(3$VA 6D$A6 L%M0F]K7.,+7(MP885 @=Q=S.8G>X.PHW)^\%N-!BK==> MUQL2%2U6L@*^N7B=K:A%L=I^4DD;A'!S)[?"[A\XN(GP>K6Z M57F]Y.4"*Z92!9 @*<")%N59,0@H&'&)0R0QL3XPIF^RJ8G]H$Y>(SY.7^&0 M:N?NPB "Q^XQN' WI-702LHQ&@Z'QK]7VZ'5S8[F0_LU[H'C,A?E2R,^WE_+ M;#'C% J.-0*)9!)@""F0<2J 3'BJF69,(.L6Q([EJ86$#;A@C_+MT]2O= MFX03R]K2?R8F@@?7DJS1AD8F$&)TUZ.S43VRW(P/2>6 MIS,S3D+M]-Y+L,T61Q-NIT-U 7J>K//Z7[%K,ES.,8P49I@"E M$*Y/9Q0P2D"H":%"P(2F5L>GM$\Q-2E7",LS0S>EXQJE:T5]R*1E23V(GU/7 MU([4N%?5K=X?MZP^G&;$["L-:"XYMFCQ::0Z8IB!E2 M $LB 9?(")UJ2!'!2B8.[Y!IG&-J(J]@[K5UN=?[49HI[;]=< 2B3JSV4W/D M\@Z9P5R-]@X9+\X:FACWT^<2HV-=T&N^!#.MA>($09 RG0+, M15E\B')_K!0"APG6T''3_>X$4PL"FTU?CR"#$J7KMK@]$ON7Z*'4G%CSCJQX M[(!K=GW WK<]@R/O>FMVYW"_6\LXG^9!1.H).=I4<1'C(1%)8C)I) $.60(X M$^5V=Z:D8 3RV.ITT8XYIB;A"N9>D8>\"N-F2FV:!X.).GGSX+0="+?;1YT#QUXOD=Y)-&[_#+[MIQ)07",TQ@@ M&F& 4QP#B4()(*.$AB3B4CJ^9_)@CJE%O_T3*ZHSK;(\*+%ZGNM1(]0VDQE$ MTSC)C!M#_N=Y''(P_#2/FLWO!\(LA>Q#PQC:M6' 7:S[WOKK M\\'2N)+<=^! A0<#?-?=EZ:XRL7B]3)5=_]6]S,B4DHB2D!2G8$;$PF$3@4( M8\Y"C1 AS.J]DZTS3%*(]\$&95#!# Q.UV5VGTC;%78 />,LKO;,>*RJ+=X/ M6%#W+8Z\EK8X=+B,M@WT>/G(YA71K^Z2S^;WIZJ^M,1(IQQ%@& M <8Q!8RB MV&32G#"M!8-*N+YZO3[!U&2\Q1AL03HV]QM)[-?P4&I.+&%'5KQ>PM[D^J 7 ML>\8'/UE[$WN-+V0O7%&ULU9Q;<]NV M$L??\RETW-<#&U<"R#3I^#AIQW.2)I.XT\YYT>"RD#F12 ])Q_:W/PM9:GR+ MPUKT4'JQ98K"8O_X<;%80/[YE\O%?/(5FK:LJU=[;)_N3: *=2RKV:N]/TY^ M)6;OE]3/ZL MFR_E5T?(Z^6'CNJSJZ:.$$D8ISXA,MB)62ZB0+ M8$#_/7O)5)% "8K78R02FR).ZX)0J74(E$M;\&6C\[+Z\C+_\*Z%"3I7MO_L<3F'A2%FUG:M"-M"6+]OEQ7=U<-U2\Q_V:_+=._)?9'T; MR9<(XT2P_R'>G&0WSHXJA&$CVZ6 M.[K\8'=U!J_VVG)Q-O_[VFD#Z=7>+)OCC%HNLK&?OGWTX)O=LP9:1&7IYSN\ ML&HAV_JG?8#+#JH(UUZMVY_7X=9-\ZQIW:P_.7<>YLNKTPCE=-GRH6^[QH5N M*FGB@J=$N+.4R*"!>&L$*5R07$G+C':W7S/ZJ\'V/!!%B*_ M6"JR5..>N6M5GM;OMU57=B6T)\[/8?SM%C MB-'JZB&TNQX9[._>!-U.T#00WUT/S'>]6[K682R%Y9U/'?3SELR<.YM^1J4A MQ]JCN6O;#^ES5X&A MF>IDN7(BD2B%)U)$1JSWE 2FA7'!X\.5G@>9NUT9EYA-Q_8N*AL)/2(I,Y@> MTGVAU>]U!^V;<\#AXRL7F"TD=44B7O) )(^4F,(J8JCS#'-W+4)Z/(%\I/5> MP\^W?/B'4F]D -@^5_2&"V+-<%3".BU)]XG CS8 M>B\ Y X ,(1ZHT> VR[HE0M6<6F=T00LIM\R,DR?H/#$L^2 <\6D,'TBP(.M M]P) [0 0Z@W.@"*W@QB=N5"$:BT,@EB S D5Q8$%9+$!)TXZL5PQ=X'@ =; M[P5 L1, ;*[>R #H??7;N6MU2^K7 O^YI98!S9GF-,^2!*\D#BS M\8(X7*$3GFS!F*!*B!]4%O^AQ5Z@Z!T Y;E4'AD>OL_XC0 HU@'0):D=DY)0 M[3$ D_$6$B$4F-58!:EZI% ?J?U7E"8'8!B"/5&!.#O>MW5<97J9K'>&8#C M#A:Y F.,=#81S65"55C>Y!$%X2Q9D-0(FN[,($^I;3]H>YPUYC#URP%5'9F- M]>;B"=X[%2 @4.H)%9@(X2-1$.\+@P\*E4F9F #X1C3JKHSK"5',3 MH\ 5$T6B,=NV@GB7MV P[_9(XY:QGI>.)^Q 5E\NOF-^G/+6 MLT(RA-!;0[>I7EH=-74S6IX339M[JEQ!Q25YX36BTD4*B(;+'3M;T MI>4!T[U(L3M%RJ8";Q,E1_CR0W-27U33 -ZXĶ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end